EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa

Cristina Tarango iD, Charles T Quinn, Bret Augsburger iD, Anne W Lucky

Pediatric Dermatology · 2023

DOI: 10.1111/pde.15239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2023. Verfasst von Cristina Tarango und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College o…. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Dystrophica, Anemia, Anemia, Iron-Deficiency, Iron Deficiencies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives To describe the prevalence, severity, and management of anemia in a cohort of children with recessive dystrophic epidermolysis bullosa (RDEB) and to highlight the use of soluble transferrin receptor (sTfR) to diagnose iron deficiency in this chronic inflammatory state.

Methods

We studied a cohort of 114 patients with RDEB followed at a pediatric hospital‐based Epidermolysis Bullosa Center from 2010 to 2020; data were prospectively tracked in a comprehensive clinical database that captured all visits, laboratory tests, iron infusions, and transfusions. The primary outcome was occurrence of anemia, which was assessed by age and sex, with and without transfusion support. Secondary outcomes included iron status using a combination of ferritin and sTfR levels, the cumulative incidence of parenteral iron therapy and transfusions, and survival.

Results

In RDEB, anemia begins in the first year of life and becomes more frequent and severe with age. The prevalence of iron deficiency anemia (IDA) estimated by ferritin was 33.6% (37/110), but the sTfR/log 10 ‐ferritin ratio indicated a 1.5‐fold higher true prevalence of IDA of 50.6% (41/81). 53.5% (61/114) received parenteral iron infusions, transfusions, or both. Higher ferritin was associated with earlier mortality.

Conclusions

Individuals with RDEB have a high burden of anemia (IDA and anemia of inflammation) that requires frequent medical interventions. The sTfR/log 10 ‐ferritin ratio improves the detection of iron deficiency in the context of inflammation and guides therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epidermolysis Bullosa DystrophicaAnemiaAnemia, Iron-DeficiencyIron DeficienciesHumansChildIronFerritinsReceptors, TransferrinInflammation

Stichwörter der Autor:innen

anemiachronic inflammationepidermolysisiron deficiency

Substanzen

IronFerritinsReceptors, Transferrin

Autor:innen und Institutionen

  • Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Dermatology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Cristina Tarango, Bret Augsburger

Zitieren

APA

Tarango, C., Quinn, C. T., Augsburger, B., & Lucky, A. W. (2023). Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa. Pediatric Dermatology. https://doi.org/10.1111/pde.15239

Vancouver

Tarango C, Quinn CT, Augsburger B, Lucky AW. Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa. Pediatric Dermatology. 2023. doi:10.1111/pde.15239

BibTeX
@article{Tarango2023,
  author = {Tarango, Cristina and Quinn, Charles T and Augsburger, Bret and Lucky, Anne W},
  title = {Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa},
  journal = {Pediatric Dermatology},
  year = {2023},
  doi = {10.1111/pde.15239}
}
Kostenlos starten →